The question is what internal assumptions are baked into FMI's existing guidance. If they anticipated getting Medicare reimbursement for NSCLC tests in early 2017, then this news wouldn't in itself cause an upward revision in guidance.
p.s. I don't follow FMI as closely as I did two years ago.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.